Human Chorionic Gonadotropin

hCG testing is covered for diagnosis and monitoring of germ cell neoplasms at specified anatomic sites and for monitoring pregnant patients with vaginal bleeding, hypertension, or suspected fetal loss. Diagnostic hCG testing is limited to once per month, while monitoring may be performed as needed; qualitative assays are not appropriate for medical management of germ cell neoplasms and are excluded for that use.

"hCG testing is covered for diagnosis or monitoring of suspected or known germ cell neoplasms of the ovary, testis, mediastinum, retroperitoneum, and central nervous system."

Sign up to see full coverage criteria, indications, and limitations.